Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation-Reference-Cited by-同舟云学术

Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation

Published:2022-12 Issue: Volume:170 Page:146-153
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Imber Brandon S.^ORCID,O'Dwyer Elisabeth,Lobaugh Stephanie,McBride Sean M.,Hopkins Margaret,Kollmeier Marisa,Gorovets Daniel,Brennan Victoria,Pike Luke R.G.,Gewanter Richard,Mychalczak Borys,Zhang Zhigang,Schöder Heiko,Zelefsky Michael J.

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

2. Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794);Swanson;Int J Radiat Oncol Bio Phy.,2005

3. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911);Bolla;Lancet North Am Ed.,2012

4. Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96–02/AUO AP 09/95 trial;Wiegel;Eur Urol.,2014

5. A phase III Multi-Centre Randomised Trial comparing adjuvant versus early salvage radiotherapy following a radical prostatectomy: results of the TROG 08.03 and ANZUP “RAVES” trial;Kneebone;Int J Radiat Oncol Bio Phy.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on 18F-DCFPyL PET/CT;Clinical Genitourinary Cancer;2024-08

2. Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial;Practical Radiation Oncology;2024-07

3. Lesion Dosimetry for [¹⁷⁷Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer;Journal of Nuclear Medicine;2023-08-31

4. Stereotactic Body Radiation Therapy Salvage for Lymph Node Recurrent Prostate Cancer in the Era of PSMA PET Imaging;Current Urology Reports;2023-07-03